224 related articles for article (PubMed ID: 19929732)
1. BMAA--an unusual cyanobacterial neurotoxin.
Vyas KJ; Weiss JH
Amyotroph Lateral Scler; 2009; 10 Suppl 2():50-5. PubMed ID: 19929732
[TBL] [Abstract][Full Text] [Related]
2. BMAA selectively injures motor neurons via AMPA/kainate receptor activation.
Rao SD; Banack SA; Cox PA; Weiss JH
Exp Neurol; 2006 Sep; 201(1):244-52. PubMed ID: 16764863
[TBL] [Abstract][Full Text] [Related]
3. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
Bradley WG; Mash DC
Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
[TBL] [Abstract][Full Text] [Related]
4. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam.
Cox PA; Banack SA; Murch SJ
Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13380-3. PubMed ID: 14612559
[TBL] [Abstract][Full Text] [Related]
5. beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-).
Liu X; Rush T; Zapata J; Lobner D
Exp Neurol; 2009 Jun; 217(2):429-33. PubMed ID: 19374900
[TBL] [Abstract][Full Text] [Related]
6. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM
J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725
[TBL] [Abstract][Full Text] [Related]
7. Detection of cyanobacterial neurotoxin β-N-methylamino-l-alanine within shellfish in the diet of an ALS patient in Florida.
Banack SA; Metcalf JS; Bradley WG; Cox PA
Toxicon; 2014 Nov; 90():167-73. PubMed ID: 25123936
[TBL] [Abstract][Full Text] [Related]
8. Animal models of BMAA neurotoxicity: a critical review.
Karamyan VT; Speth RC
Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417
[TBL] [Abstract][Full Text] [Related]
9. BMAA and Neurodegenerative Illness.
Cox PA; Kostrzewa RM; Guillemin GJ
Neurotox Res; 2018 Jan; 33(1):178-183. PubMed ID: 28540663
[TBL] [Abstract][Full Text] [Related]
10. Metabotropic glutamate receptor 1 mediates the electrophysiological and toxic actions of the cycad derivative beta-N-Methylamino-L-alanine on substantia nigra pars compacta DAergic neurons.
Cucchiaroni ML; Viscomi MT; Bernardi G; Molinari M; Guatteo E; Mercuri NB
J Neurosci; 2010 Apr; 30(15):5176-88. PubMed ID: 20392940
[TBL] [Abstract][Full Text] [Related]
11. Possible therapy for ALS based on the cyanobacteria/BMAA hypothesis.
Bradley WG
Amyotroph Lateral Scler; 2009; 10 Suppl 2():118-23. PubMed ID: 19929743
[TBL] [Abstract][Full Text] [Related]
12. The cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis.
Banack SA; Caller TA; Stommel EW
Toxins (Basel); 2010 Dec; 2(12):2837-50. PubMed ID: 22069578
[TBL] [Abstract][Full Text] [Related]
13. The cycad neurotoxic amino acid, beta-N-methylamino-L-alanine (BMAA), elevates intracellular calcium levels in dissociated rat brain cells.
Brownson DM; Mabry TJ; Leslie SW
J Ethnopharmacol; 2002 Oct; 82(2-3):159-67. PubMed ID: 12241991
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal infusion of BMAA induces selective motor neuron damage and astrogliosis in the ventral horn of the spinal cord.
Yin HZ; Yu S; Hsu CI; Liu J; Acab A; Wu R; Tao A; Chiang BJ; Weiss JH
Exp Neurol; 2014 Nov; 261():1-9. PubMed ID: 24918341
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm.
Papapetropoulos S
Neurochem Int; 2007 Jun; 50(7-8):998-1003. PubMed ID: 17296249
[TBL] [Abstract][Full Text] [Related]
16. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam.
Murch SJ; Cox PA; Banack SA
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12228-31. PubMed ID: 15295100
[TBL] [Abstract][Full Text] [Related]
17. l-Serine Reduces Spinal Cord Pathology in a Vervet Model of Preclinical ALS/MND.
Davis DA; Cox PA; Banack SA; Lecusay PD; Garamszegi SP; Hagan MJ; Powell JT; Metcalf JS; Palmour RM; Beierschmitt A; Bradley WG; Mash DC
J Neuropathol Exp Neurol; 2020 Apr; 79(4):393-406. PubMed ID: 32077471
[TBL] [Abstract][Full Text] [Related]
18. Bicarbonate dependence of glutamate receptor activation by beta-N-methylamino-L-alanine: channel recording and study with related compounds.
Weiss JH; Christine CW; Choi DW
Neuron; 1989 Sep; 3(3):321-6. PubMed ID: 2561969
[TBL] [Abstract][Full Text] [Related]
19. Beta-methylamino-alanine (BMAA) injures hippocampal neurons in vivo.
Buenz EJ; Howe CL
Neurotoxicology; 2007 May; 28(3):702-4. PubMed ID: 17379313
[TBL] [Abstract][Full Text] [Related]
20. Morphometric and neurochemical alterations found in l-BMAA treated rats.
de Munck E; Muñoz-Sáez E; Miguel BG; Solas MT; Martínez A; Arahuetes RM
Environ Toxicol Pharmacol; 2015 May; 39(3):1232-45. PubMed ID: 26002186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]